Articles

Purdue startup focuses on prostate cancer therapy

Research developed at Purdue University and licensed by a biomedical startup could give patients with late-stage prostate cancer an alternative to hormone therapies that can develop resistance after prolonged use.

Read More
Eli Lilly headquarters

Lilly pledges $90 million to improve global drug access

Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.

Read More

Dental school launches $21.6M expansion project

The school, on the IUPUI campus, broke ground Sept. 23 on the 45,000-square-foot addition. It will house 125 new patient treatment rooms, spread over three floors, that will provide more elbow room for dentists, faculty and patients.

Read More

Analysis: Diabetes drug price war likely to claim more casualties

Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.

Read More